This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It describes the requirements for collecting, storing, processing, managing and sharing health-related registry data.
Study Type
OBSERVATIONAL
Enrollment
8,000
This is a health data registry.
University Hospital Basel
Basel, Canton of Basel-City, Switzerland
RECRUITINGIn-Hospital all-cause mortality occurring before discharge from the participating study centre
In-hospital all-cause mortality is defined as death occurring before discharge from the participating study centre. Deaths occurring after transfer to an external hospital are not counted as in-hospital deaths, but are captured through follow-up for 30-day and 90-day mortality.
Time frame: 10 years
30-day and 90-day all-cause Mortality
30-day and 90-day all-cause mortality occuring after discharge from the participating study centre.
Time frame: 30, 90 days
Need for organ support at any time during hospitalization
The need for organ support at any time during hospitalization (including renal replacement therapy, mechanical circulation support irrespective of type, and vasoactive or inotropic therapy)
Time frame: 30, 60, 360 days
Acute kidney injury (AKI) within 36 hours after index diagnosis of cardiogenic shock/index presentation
Occurence of AKI (defined as an increase in serum creatinine of at least 26 µmol/L (0.3 mg/dL)
Time frame: Within 36 hours after index diagnosis of cardiogenic shock/ index presentation.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.